Recruiting

Social Cognition and Iron Dysregulation in Schizophrenia: A Longitudinal Study

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to observe changes in your ability to understand others' mental states, attributional style, emotion recognition, and emotion regulation choice over time, if you are an individual diagnosed with schizophrenia.

What is being collected

Data Collection

Collected from today forward - Prospective
DNA Samples
Who is being recruted

Self-Control+7

+ Behavior

+ Mental Disorders

From 18 to 70 Years
+9 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: September 2026
See protocol details

Summary

Principal SponsorMedical University Innsbruck
Study ContactChristopher Schaar, M.Sc.More contacts
Last updated: October 2, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: September 1, 2026

Actual date on which the first participant was enrolled.

This study focuses on understanding how schizophrenia impacts social thinking, emotion regulation, brain function, and biological processes over time. It involves two groups: individuals diagnosed with schizophrenia and healthy adults without schizophrenia. The goal is to compare how these aspects change in people with schizophrenia compared to healthy adults, which could help improve our understanding and care for this condition. The study also aims to explore how these changes differ from normal aging. Participants from both groups will complete a series of behavioral tasks and questionnaires at three different times: at the start of the study, after one year, and after two years. These tasks assess abilities such as understanding others, processing social information, and regulating emotions. For those with schizophrenia, clinical symptoms and their severity will also be assessed. Blood and hair samples will be collected at all visits to investigate biological factors related to mental health and stress. Participants will also undergo an MRI brain scan at the start and after one year. The study's outcomes include changes in the ability to understand others' mental states, attributional style, emotion recognition, and emotion regulation choice.

Principal SponsorMedical University Innsbruck
Study ContactChristopher Schaar, M.Sc.More contacts
Last updated: October 2, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

180 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 18 to 70 Years

Range of ages for which participants are eligible to join.

Healthy volunteers allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Self-ControlBehaviorMental DisordersCognition DisordersSocial BehaviorNeurocognitive DisordersSchizophrenia Spectrum and Other Psychotic DisordersEmotional RegulationSchizophreniaCognitive Dysfunction

Criteria

3 inclusion criteria required to participate
Inclusion criteria (SZ only)

age 18-70 years at baseline; normal or corrected-to-normal vision; sufficient hearing; fluency in German; willingness and ability to understand and comply with study procedures. Participants must either be healthy adults without any mental health disorder (HC) or have a confirmed DSM-5 diagnosis of SZ

clinical stability at assessment, defined as no clinically significant change in psychopathological symptoms and no modification of pharmacotherapy for at least three months prior to study entry, as confirmed by the treating psychiatrist; full remission is not required

6 exclusion criteria prevent from participating
Additional Eligibility Criteria for Cycle-Timed Neuroimaging

Exclusion criteria (HC only)

To minimize hormonal confounding of emotion-regulation-related neural measures, menstruating female participants will be scanned in the early follicular phase (cycle days 1-6), requiring regular menstrual cycles (21-35 days) and a negative pregnancy test at relevant visits

Use of hormonal contraception will be recorded

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology; Medical University of Innsbruck

Innsbruck, AustriaOpen Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology; Medical University of Innsbruck in Google Maps
Recruiting
One Study Center